Posted on

CEPI

Vaccine development

CEPI has moved quickly and collaboratively to rapidly develop vaccines against the COVID-19 virus. CEPI is also collaborating with GSK and will use their pandemic vaccine adjuvant platform technology to enhance the development of an effective vaccine.

Help CEPI develop a COVID-19 vaccine

CEPI estimates that it will cost $2 billion to develop this vaccine within the next 12-18 months. So far they have raised over $750 million towards this goal. They are seeking further contributions from individuals and institutions.